A 61-year-old man with a history of hypertension and multiple sclerosis attended the emergency department on March 14 with symptoms of fever, vomiting and dyspnea for 4 days.
He was hypoxemic, with oxygen saturation of 90% in ambient air and feverish at 38.5 Â°C.
A chest X-ray showed bilateral alveolar opacities, more severe in the right lung.
A flu test was negative.
The nasopharyngeal smear sent for a SARS-CoV-2 PCR test was positive.
On March 15th (day 5 of symptoms), the patient's hypoxemia worsened and was admitted to the ICU, where he was intubated and mechanical ventilation was applied.
C-reactive protein was 338 mg/dL and lactate dehydrogenase was 714 U/L.
It met the criteria for severe RAAS, with a PaO2/FiO2 ratio of 73.
The patient was treated with a protocol of daily placement in prone position.
He developed acute kidney injury, which required CRRT on March 17.
A review of the medical history revealed no history of chronic nephropathy.
Due to the closure of the dialysis circuit, the patient was treated with continuous infusion of heparin, not administered.
Medication was prescribed with a prescription (500 mg per day IV).
), ceftriaxone (1 g a day, IV.
), hydroxychloroquine (initial dose of 800 mg, then 400 mg daily) and dexamethasone (20 mg daily IV).
Despite attempts to remove the patient from mechanical ventilation, she was not able to breathe on her own and maintained ventilation during her stay in the ICU.
On March 30, the patient developed vasopressive therapy-resistant shock and died on March 26th.
